Author Identifier

Rasheed Abdulraheem: https://orcid.org/0000-0002-8519-8508

Date of Award

2026

Keywords

Alzheimer's disease, Beta-amyloid, Sorghum bicolor, polyphenols, complementary therapy

Document Type

Thesis

Publisher

Edith Cowan University

Degree Name

Doctor of Philosophy

School

School of Medical and Health Sciences

First Supervisor

W.M.A.D. Binosha Fernando

Second Supervisor

Prashant Bharadwaj

Third Supervisor

Ralph Martins

Fourth Supervisor

Zhaoyu Li

Fifth Supervisor

Ranil Coorey

Abstract

There is growing interest in safe, affordable, and biocompatible plant-based therapies to support individuals with Alzheimer’s disease (AD). Sorghum bicolor, the world’s fifth most important cereal grain, is rich in nutrients and bioactive compounds; however, its potential as a functional food for neuroprotection has largely been overlooked. To address this gap, this thesis undertakes a multidisciplinary investigation of sorghum polyphenol extracts, with particular emphasis on the unique 3-deoxyanthocyanidins (3-DXAs), to determine their potential to mitigate AD-related pathology.

The thesis progresses systematically from literature review to chemical characterisation, mechanistic studies, and whole-organism validation. Chapter 2 reviews current evidence linking dietary polyphenols to AD prevention and management, identifying key knowledge gaps. Chapter 3 characterises the polyphenol composition of different sorghum genotypes, providing novel phytochemical insights. Chapter 4 examines the effects of crude and purified polyphenol extracts on beta-amyloid 42 (Aβ₄₂) aggregation and neurotoxicity, integrating transcriptomic analyses to elucidate underlying molecular mechanisms. Chapter 5 focuses on 3-DXAs (apigeninidin chloride, luteolinidin chloride, and 7-methoxyapigeninidin chloride), combining molecular dynamics simulations with cell-based assays to clarify mechanisms of action. Chapter 6 validates neuroprotective effects in vivo using transgenic Caenorhabditis elegans models, assessing behavioural functions, neuronal integrity, and lifespan.

Comprehensive phytochemical profiling of black, red-brown, and red sorghum identified 29 distinct polyphenols, including five (astilbin, apigetrin, oninin, 5-O-methylgenistein, and neochlorogenic acid) reported in sorghum for the first time. Black sorghum exhibited the richest and most diverse composition. In vitro studies using MC-65 human neuroblastoma cells demonstrated that both crude and purified extracts, as well as individual 3-DXAs, exerted multitarget neuroprotective effects. These include inhibition of Aβ₄₂ aggregation, reduction of neurotoxicity, attenuation of oxidative stress, and preservation of mitochondrial function. Transcriptomic analyses further revealed downregulation of pro-inflammatory and AD related genes within the MAPK/NF-κB signalling pathway. In vivo validation in transgenic C. elegans corroborated these findings, with extracts reducing neurodegeneration, improving behavioural function, and marginally extending lifespan.

Collectively, these results provide the first comprehensive evidence that sorghum polyphenol extracts exert multitarget neuroprotective effects relevant to AD. This work expands the phytochemical understanding of sorghum, establishes its potential as an affordable functional food-based intervention, and lays a strong foundation for translational research, including bioavailability, pharmacokinetics, and future clinical trials.

Access Note

Access to this thesis is embargoed until 25th April 2029

Available for download on Wednesday, April 25, 2029

Included in

Neurology Commons

Share

 
COinS
 

Link to publisher version (DOI)

10.25958/bqq9-b321